Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Leukemia
|
February 1, 1997
Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis
A König, T Menzel, S Lynen, et al.
Anti-Cancer Drugs
|
June 1, 1995
The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma
A Maki, H Diwakaran, B Redman, et al.
Leukemia & Lymphoma
|
February 26, 1999
Expression of membrane-associated macrophage colony-stimulating factor (M-CSF) in Hodgkin's disease and other hematologic malignancies
G G Zheng, K F Wu, Y Q Geng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 1998
Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1
R M Mohammad, M L Varterasian, V P Almatchy, et al.
Radiation Oncology Investigations
|
July 16, 1999
Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma
A Aref, S Narayan, S Tekyi-Mensah, et al.
Leukemia Research
|
September 1, 1995
Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma
R M Mohammad, H Diwakaran, A Maki, et al.
Experimental Hematology
|
January 1, 1993
Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro
A al-Katib, R M Mohammad, M Dan, et al.
Cancer
|
February 15, 1994
Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease
M R Smith, P S Khanuja, A al-Katib, et al.
International Journal of Oncology
|
July 13, 1999
A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model
R M Mohammad, C Limvarapuss, N R Wall, et al.
Cancer
|
June 1, 1984
Treatment of diffuse poorly differentiated lymphocytic lymphoma. An analysis of prognostic variables
A Al-Katib, B Koziner, E Kurland, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Leukemia
|
February 1, 1997
Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis
A König, T Menzel, S Lynen, et al.
Anti-Cancer Drugs
|
June 1, 1995
The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma
A Maki, H Diwakaran, B Redman, et al.
Leukemia & Lymphoma
|
February 26, 1999
Expression of membrane-associated macrophage colony-stimulating factor (M-CSF) in Hodgkin's disease and other hematologic malignancies
G G Zheng, K F Wu, Y Q Geng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 1998
Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1
R M Mohammad, M L Varterasian, V P Almatchy, et al.
Radiation Oncology Investigations
|
July 16, 1999
Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma
A Aref, S Narayan, S Tekyi-Mensah, et al.
Leukemia Research
|
September 1, 1995
Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma
R M Mohammad, H Diwakaran, A Maki, et al.
Experimental Hematology
|
January 1, 1993
Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro
A al-Katib, R M Mohammad, M Dan, et al.
Cancer
|
February 15, 1994
Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease
M R Smith, P S Khanuja, A al-Katib, et al.
International Journal of Oncology
|
July 13, 1999
A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model
R M Mohammad, C Limvarapuss, N R Wall, et al.
Cancer
|
June 1, 1984
Treatment of diffuse poorly differentiated lymphocytic lymphoma. An analysis of prognostic variables
A Al-Katib, B Koziner, E Kurland, et al.
Page
of 8